SuPAR in major depression: Association with 26 weeks antidepressant response and 10-year depression outcomes

INTRODUCTION: Inflammation has been associated with depression and differential antidepressant (AD) treatment response. Soluble urokinase plasminogen activator receptor (suPAR) is a novel measure of chronic inflammation. We investigated whether suPAR is associated with depression severity and AD res...

Descripción completa

Detalles Bibliográficos
Autores principales: Haupt, T.H., Elfving, B., Eugen-Olsen, J., Mors, O., Köhler-Forsberg, O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507069/
https://www.ncbi.nlm.nih.gov/pubmed/37731957
http://dx.doi.org/10.1016/j.bbih.2023.100685

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10507069/
https://www.ncbi.nlm.nih.gov/pubmed/37731957
http://dx.doi.org/10.1016/j.bbih.2023.100685

Ejemplares similares